281 related articles for article (PubMed ID: 8496678)
41. Deletion of repeats in the alpha C protein enhances the pathogenicity of group B streptococci in immune mice.
Gravekamp C; Rosner B; Madoff LC
Infect Immun; 1998 Sep; 66(9):4347-54. PubMed ID: 9712787
[TBL] [Abstract][Full Text] [Related]
42. Inactivation of the alpha C protein antigen gene, bca, by a novel shuttle/suicide vector results in attenuation of virulence and immunity in group B Streptococcus.
Li J; Kasper DL; Ausubel FM; Rosner B; Michel JL
Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13251-6. PubMed ID: 9371832
[TBL] [Abstract][Full Text] [Related]
43. Molecular analysis of clinical group B streptococcal strains by use of alpha and beta gene probes.
Suvorov A; Dmitriev A; Ustinovitch I; Schalén C; Totolian AA
FEMS Immunol Med Microbiol; 1997 Mar; 17(3):149-54. PubMed ID: 9093835
[TBL] [Abstract][Full Text] [Related]
44. Molecular diversity among the trypsin resistant surface proteins of group B streptococci.
Flores AE; Ferrieri P
Zentralbl Bakteriol; 1996 Sep; 285(1):44-51. PubMed ID: 8946695
[TBL] [Abstract][Full Text] [Related]
45. Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat region epitopes.
Bessen D; Fischetti VA
J Immunol; 1990 Aug; 145(4):1251-6. PubMed ID: 1696296
[TBL] [Abstract][Full Text] [Related]
46. Cell surface polysaccharide and protein antigens of an encapsulated Porphyromonas gingivalis 16-1 strain.
Ro M; Naito Y; Okuda K
Bull Tokyo Dent Coll; 1995 Feb; 36(1):43-8. PubMed ID: 8689741
[TBL] [Abstract][Full Text] [Related]
47. Expression of group B protective surface protein (BPS) by invasive and colonizing isolates of group B streptococci.
Flores AE; Chhatwal GS; Hillier SL; Baker CJ; Ferrieri P
Curr Microbiol; 2014 Dec; 69(6):894-8. PubMed ID: 25108378
[TBL] [Abstract][Full Text] [Related]
48. Mouse-protective antibodies against the Ibc proteins of group B streptococci.
Bevanger L; Naess AI
Acta Pathol Microbiol Immunol Scand B; 1985 Apr; 93(2):121-4. PubMed ID: 3893032
[TBL] [Abstract][Full Text] [Related]
49. Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine.
Stover CK; Bansal GP; Hanson MS; Burlein JE; Palaszynski SR; Young JF; Koenig S; Young DB; Sadziene A; Barbour AG
J Exp Med; 1993 Jul; 178(1):197-209. PubMed ID: 8315378
[TBL] [Abstract][Full Text] [Related]
50. Group B streptococci escape host immunity by deletion of tandem repeat elements of the alpha C protein.
Madoff LC; Michel JL; Gong EW; Kling DE; Kasper DL
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4131-6. PubMed ID: 8633028
[TBL] [Abstract][Full Text] [Related]
51. [The c protein fractions of group B streptococci: its distribution and relation to heat-labile antigens for the agglutination method].
Yasuda T; Suzuki R; Okitsu T; Asai Y; Matsushima A; Takizawa K
Kansenshogaku Zasshi; 1989 Nov; 63(11):1281-6. PubMed ID: 2689530
[TBL] [Abstract][Full Text] [Related]
52. The putative R1 protein of Streptococcus agalactiae as serotype marker and target of protective antibodies.
Moyo SR; Maeland JA; Lyng RV
APMIS; 2001 Dec; 109(12):842-8. PubMed ID: 11846725
[TBL] [Abstract][Full Text] [Related]
53. Structural identification of a key protective B-cell epitope in Lyme disease antigen OspA.
Ding W; Huang X; Yang X; Dunn JJ; Luft BJ; Koide S; Lawson CL
J Mol Biol; 2000 Oct; 302(5):1153-64. PubMed ID: 11183781
[TBL] [Abstract][Full Text] [Related]
54. Immunochemistry of capsular type polysaccharide and virulence properties of type VI Streptococcus agalactiae (group B streptococci).
von Hunolstein C; D'Ascenzi S; Wagner B; Jelínková J; Alfarone G; Recchia S; Wagner M; Orefici G
Infect Immun; 1993 Apr; 61(4):1272-80. PubMed ID: 8454331
[TBL] [Abstract][Full Text] [Related]
55. Identification and characterization of an antigen I/II family protein produced by group A Streptococcus.
Zhang S; Green NM; Sitkiewicz I; Lefebvre RB; Musser JM
Infect Immun; 2006 Jul; 74(7):4200-13. PubMed ID: 16790795
[TBL] [Abstract][Full Text] [Related]
56. Determination of epidemiological relationships of Streptococcus agalactiae isolated from bovine mastitis.
Merl K; Abdulmawjood A; Lämmler C; Zschöck M
FEMS Microbiol Lett; 2003 Sep; 226(1):87-92. PubMed ID: 13129612
[TBL] [Abstract][Full Text] [Related]
57. Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii.
Huang W; Yao Y; Wang S; Xia Y; Yang X; Long Q; Sun W; Liu C; Li Y; Chu X; Bai H; Yao Y; Ma Y
Sci Rep; 2016 Feb; 6():20724. PubMed ID: 26853590
[TBL] [Abstract][Full Text] [Related]
58. In silico analysis of candidate proteins sharing homology with Streptococcus agalactiae proteins and their role in male infertility.
Parida R; Samanta L
Syst Biol Reprod Med; 2017 Feb; 63(1):15-28. PubMed ID: 27802063
[TBL] [Abstract][Full Text] [Related]
59. Identification of the gene encoding a 38-kilodalton immunogenic and protective antigen of Streptococcus suis.
Okwumabua O; Chinnapapakkagari S
Clin Diagn Lab Immunol; 2005 Apr; 12(4):484-90. PubMed ID: 15817754
[TBL] [Abstract][Full Text] [Related]
60. Novel aspects of the Z and R3 antigens of Streptococcus agalactiae revealed by immunological testing.
Maeland JA; Radtke A; Lyng RV; Mavenyengwa RT
Clin Vaccine Immunol; 2013 Apr; 20(4):607-12. PubMed ID: 23408530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
